Robust COX-2-mediated prostaglandin response may drive arthralgia and bone destruction in patients with chronic inflammation post-chikungunya.
Patients following infection by chikungunya virus (CHIKV) can suffer for months to years from arthralgia and arthritis. Interestingly, methotrexate (MTX) a major immune-regulatory drug has proved to be of clinical benefit. We have previously shown that CHIKV can persist in the joint of one patient 1...
Saved in:
Main Authors: | Yosra Bedoui (Author), Axelle Septembre-Malaterre (Author), Claude Giry (Author), Marie-Christine (Author), Jimmy Selambarom (Author), Pascale Guiraud (Author), Philippe Gasque (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunomodulatory drug methotrexate used to treat patients with chronic inflammatory rheumatisms post-chikungunya does not impair the synovial antiviral and bone repair responses.
by: Yosra Bedoui, et al.
Published: (2018) -
Focus on the high therapeutic potentials of quercetin and its derivatives
by: Axelle Septembre-Malaterre, et al.
Published: (2022) -
In Vitro Analyses of the Multifocal Effects of Natural Alkaloids Berberine, Matrine, and Tabersonine against the O'nyong-nyong Arthritogenic Alphavirus Infection and Inflammation
by: Anne-Laure Sandenon Seteyen, et al.
Published: (2023) -
Chikungunya-Driven Gene Expression Linked to Osteoclast Survival and Chronic Arthralgia
by: Alysson Henrique Urbanski, et al.
Published: (2024) -
In Vivo Evaluation of -Based Indian Traditional Formulation (), Against Chikungunya Virus-Induced Morbidity and Arthralgia
by: Jaspreet Jain MSc, et al.
Published: (2018)